Enovis Surgical

DJO Global is a global developer, manufacturer, and distributor of high-quality medical devices that provide solutions for musculoskeletal health, vascular health, and pain management. The Company’s products address the continuum of patient care from injury prevention to rehabilitation after surgery, injury or from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers and other healthcare professionals. In addition, many of the Company’s medical devices and related accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. The Company’s product lines include rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management and physical therapy products. The Company’s surgical division offers a comprehensive suite of reconstructive joint products for the hip, knee, and shoulder. DJO Global’s products are marketed under a portfolio of brands including Aircast®, Chattanooga, CMF™, Compex®, DonJoy®, Empi®, ProCare®, DJO® Surgical, Dr. Comfort®, and Exos™.

Michael P. Mogul

President, CEO and Director

Mark Nordquist

Founder

5 past transactions

Mathys

Acquisition in 2021
Mathys develops, produces and distributes products for artificial joint replacement, synthetic bone graft substitute and sports medicine.

MedShape

Acquisition in 2021
MedShape is a privately held medical device company founded in 2005 based on a portfolio of proprietary surgical solutions that use its patented adaptive shape memory healing technologies to address the increasing demand for improved joint fusion, sports medicine, and musculoskeletal trauma products. MedShape® has enjoyed long-term support from Hills Capital Management, the Georgia Research Alliance (GRA), the National Science Foundation (NSF), the National Institutes of Health (NIH), and In-Q-Tel.

Trilliant Surgical

Acquisition in 2021
Trilliant Surgical provides small bone implants to podiatrists and orthopedic surgeons. Their focus is on bone and joint elective and trauma procedures for the foot and ankle. They remain committed to the innovation of podiatric implants and surgical instrumentation with a strong focus on brilliant design, development, and distribution.

LiteCure

Acquisition in 2020
Combining physics, laser science, and engineering, LiteCure is a leading medical device manufacturing company bringing advanced laser technology and innovative solutions to the health care industry. LiteCure Medical is a division of LiteCure, LLC. LiteCure is the parent company of Companion Therapy and LiteCure Medical. LiteCure is a registered manufacturer providing FDA cleared products for a variety of medical applications. Each product has been designed and manufactured under stringent quality control systems that are certified to meet ISO-9001 and ISO-13485 standards for medical devices.

Iomed

Acquisition in 2007
IOMED, Inc.develops, manufactures and commercializes controllable drug delivery systems using iontophoretic technology. Iontophoresis is a non-invasive method of enhancing and controlling the transport of water-soluble ionic drugs into and through the skin using a low level electrical current. The Company's proprietary iontophoretic drug delivery systems allow rapid onset and cessation of therapeutic action, as well as programmable dose control. The systems enable caregivers and patients to control the onset of drug effectiveness and maintain, reduce or cease drug administration once a desired therapeutic effect is observed. The programming feature also enables caregivers to customize dosing patterns to meet each patient's specific needs. The Company is developing systems designed to enable patient monitoring and control. The flexibility of the Company's proprietary systems provides therapeutic control not possible with many alternative drug delivery methods, including oral tablets and capsules, injections, inhalants and passive transdermal patches. The Company's systems may also increase bioavailability, safety and patient comfort.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.